ASHLEY DUMAS: Open Payments
NPI 1285993295 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,305 in 66 payments from 16 companies in 2025. Trend: 2023 $2,126 · 2024 $1,726 · 2025 $1,305
Food & beverage: $1,305
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 10 | $209 |
| Teva Pharmaceuticals USA, Inc. | 12 | $207 |
| Axsome Therapeutics, Inc. | 7 | $145 |
| Tris Pharma Inc | 6 | $128 |
| Janssen Pharmaceuticals, Inc | 6 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| Alkermes, Inc. | 3 | $61 |
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Vertical Pharmaceuticals, LLC | 3 | $45 |
Products named: Azstarys, Auvelity, UZEDY, Dyanavel XR, SPRAVATO, TRINTELLIX, CAPLYTA, AUSTEDO XR.
Industry payments across AR — which companies pay providers there.
